Apasomics is a biotechnology company pioneering bone-targeted drug delivery to transform the treatment of osteoporosis, and skeletal disorders. Our apasome-based nanocarriers deliver bisphosphonates directly to the bone, ensuring maximum efficacy while minimizing side effects. By combining nanotechnology, precision medicine, and advanced drug delivery, we aim to revolutionize bone health treatments—enhancing therapeutic outcomes, improving patient quality of life, and opening new frontiers in regenerative medicine.
